RPA
VERA icon

Redwood Park Advisors’s Vera Therapeutics VERA Stock Holding History

Redwood Park Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Hold
500
– – 0.01% 155
2026
Q1 		$20.1K Hold
500
– – 0.01% 152
2025
Q4 		$25.3K Hold
500
– – 0.02% 145
2025
Q3 		$14.5K Hold
500
– – 0.01% 160
2025
Q2 		$11.8K Hold
500
– – 0.01% 163
2025
Q1 		$12K Hold
500
– – 0.01% 156
2024
Q4 		$21.1K Buy
+500
New +$22.1K 0.01% 141

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redwood Park Advisors's VERA Position: Q2 2026 in Review

Redwood Park Advisors held its Vera Therapeutics (VERA) position steady in Q2 2026 at 500 shares worth $21.5K. The position accounts for 0.01% of the portfolio, ranked #155.

Redwood Park Advisors first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.3K in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Redwood Park Advisors held 500 shares of Vera Therapeutics worth $21.5K as of Q2 2026.
  • Redwood Park Advisors left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 0.01% of Redwood Park Advisors's portfolio in Q2 2026, its #155 holding.
  • Redwood Park Advisors first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Redwood Park Advisors's Vera Therapeutics position peaked at $25.3K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.